Pulmonary Circulation (Jul 2024)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

  • Diederik P. Staal,
  • Paul M. Hendriks,
  • Mitch C. J. vanThor,
  • Liza D. van deGroep,
  • Leon M. van denToorn,
  • Berend‐Jan M. Mulder,
  • Prewesh P. Chandoesing,
  • Robert M. Kauling,
  • Sanne Boerman,
  • Annemien E. van denBosch,
  • Johannes J. Mager,
  • Karin A. Boomars,
  • Martijn C. Post

DOI
https://doi.org/10.1002/pul2.12419
Journal volume & issue
Vol. 14, no. 3
pp. n/a – n/a

Abstract

Read online

Abstract Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH‐specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.

Keywords